Recent News & Events

A team of biologists from San Diego State University discovered that corals and seaweeds have the ability to choose the types of bacteria present among the waters of tropical reef.

A team of researchers from the UC Santa Barbara has demonstrated the Cholinergic Amacrine Cell’s self-spacing behavior...

A team of researchers from the University of Kentucky in Lexington successfully altered the structure of the bacterial enzyme produced ...

A team of clinical researchers from the University of Texas Medical Branch at Galveston, the Uniformed Services University of the Health ...

A group of molecular biologists from the University of Wyoming have successfully modified the genetic makeup of a new breed of goats that contain golden orb spider genes, allowing them to produce milk laden with spider silk proteins.

Bluebird Bio, a clinical biotechnology specialist firm dedicated to groundbreaking gene therapy discoveries for acute genetic and orphan disorders, developed and utilized its gene therapy to help transform the lives and well-being of patients with a rare genetic blood disease called beta-thalassemia.

A team of scientific researchers from the University of Oregon conducted an applied microbiology study aimed at determining the type of bacteria that thrive on smartphones and on the skin of a person as well as his or her nearby environments. This new study published in the PeerJ Journal’s June issue showed findings that offer great potential in helping forensic investigations, human diseases researches, and infection control experiments in the future.

A team of researchers from the University of Washington (UW) recently published in the journal, Nature Biotechnology, a study on their newly discovered low-cost and faster technique in reading longer DNA sequences, called nanopore DNA sequencing.

The use of automation healthcare technology equipment is fast becoming a major trend in the clinical and pharmaceutical industries as it offers advantages such as laboratory efficiency as well as product safety and quality.

At the World Stem Cells and Regenerative Medicine Congress held in London last 2013, Dr. Aby Mathew, BioLife Solutions’ Senior Vice President and Chief Technology Officer discussed about how vital biopreservation (upstream and downstream) is to every bioprocess in order to contribute to successful cell therapy product commercialization.

A group of researchers from Vanderbilt University, led by Sean Davies, discovered that the genetically altered Escherichia coli (E. coli) bacteria strain extracted in the gut have a huge potential for weight loss as tested on laboratory mice, according to a study published in the Journal of Clinical Investigation.

U.S. health authorities and global health organizations have escalated efforts to help bring the raging Ebola outbreak under control. Despite the risk of infection, two of the American healthcare workers, Dr. Nahid Bhadelia and Dr. Guillermo Madico from the National Emerging Infectious Diseases Laboratory in Boston are set to continue their mission on battling the growing epidemic in West Africa.

The United States Pharmacopeial Convention and the National Formulary (USP-NF) recently unveiled the (Compounding Expert Committee) new proposed General Chapter 800 Hazardous Drugs – Handling in Healthcare Settings.

In this year’s Annual Meeting & Food Expo at the Institute of Food Technologists (IFT), a team of food scientists showcased a new presentation that introduced the idea of masking or blocking the bitter taste in food to make it palatable enough for consumers with genetically sensitive palates.

Four major scientific research agencies – namely: AgResearch, the Ministry for Primary Industries (MPI), AsureQuality, and Environmental Science and Research (ESR) – collaborated to plan the construction of a state-of-the-art animal research laboratory and high-security biocontainment facility worth $65 million in Upper Hutt City, New Zealand.

In an investigation by the Center for Disease Control and Prevention (CDC) of the origin to the Salmonella typhimurium outbreak in 13 different states last November, clinical test findings revealed that all those infected individuals reported common precedents of working in a biology or microbiology laboratory prior to the outbreak.